Stay updated on IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers
Sign up to get notified when there's something new on the IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers page.

Latest updates to the IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new study on immunotherapy for head and neck cancer, which includes specific inclusion criteria and a new principal investigator. The revision number has also changed, indicating an update in the study's protocol.SummaryDifference39%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers
Enter your email address, and we'll notify you when there's something new on the IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers page.